Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1

Journal of Virology

Volumn 82, Issue 19, 2008, Pages 9795-9799

  Foxall, Russell B ^a   Cortesão, Catarina S ^a   Albuquerque, Adriana S ^a   Soares, Rui S ^a   Victorino, Rui M M ^a,b   Sousa, Ana E ^a,c  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOREACTIVITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNE SYSTEM; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PROGNOSIS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 52649152365     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01217-08     Document Type: Article

References (30)

1. Adjorlolo-Johnson, G., K. M. De Cock, E. Ekpini, K. M. Vetter, T. Sibailly, K. Brattegaard, D. Yavo, R. Doorly, J. P. Whitaker, L. Kestens, et al. 1994. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 272:462-466.
2. Alatrakchi, N., F. Damond, S. Matheron, S. Beretta-Tempelhoff, P. Campa, G. Carcelain, F. Brun-Vezinet, and B. Autran. 2006. Proliferative, IFN-gamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection. AIDS 20:29-34.
3. Ariyoshi, K., F. Cham, N. Berry, S. Jaffar, S. Sabally, T. Corrah, and H. Whittle. 1995. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 9:555-559.
4. Bertoletti, A., F. Cham, S. McAdam, T. Rostron, S. Rowland-Jones, S. Sabally, T. Corrah, K. Ariyoshi, and H. Whittle. 1998. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J. Virol. 72:2439-2448.
5. Drylewicz, J., S. Matheron, E. Lazaro, F. Damond, F. Bonnet, F. Simon, F. Dabis, F. Brun-Vezinet, G. Chene, and R. Thiebaut. 2008. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS 22:457-468.
6. Duvall, M. G., A. Jaye, T. Dong, J. M. Brenchley, A. S. Alabi, D. J. Jeffries, M. van der Sande, T. O. Togun, S. J. McConkey, D. C. Douek, A. J. McMichael, H. C. Whittle, R. A. Koup, and S. L. Rowland-Jones. 2006. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176:6973-6981.
7. Duvall, M. G., M. L. Precopio, D. A. Ambrozak, A. Jaye, A. J. McMichael, H. C. Whittle, M. Roederer, S. L. Rowland-Jones, and R. A. Koup. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38:350-363.
8. Gillespie, G. M., S. Pinheiro, M. Sayeid-Al-Jamee, A. Alabi, S. Kaye, S. Sabally, R. Sarge-Njie, H. Njai, K. Joof, A. Jaye, H. Whittle, S. Rowland-Jones, and L. Dorrell. 2005. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur. J. Immunol. 35:1445-1453.
9. Gotch, F., S. N. McAdam, C. E. Allsopp, A. Gallimore, J. Elvin, M. P. Kieny, A. V. Hill, A. J. McMichael, and H. C. Whittle. 1993. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 151:3361-3369.
10. Grossman, Z., M. Meier-Schellersheim, A. E. Sousa, R. M. Victorino, and W. E. Paul. 2002. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med. 8:319-323.
11. + T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77:10900-10909.
12. Jaffar, S., A. Wilkins, P. T. Ngom, S. Sabally, T. Corrah, J. E. Bangali, M. Rolfe, and H. C. Whittle. 1997. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:327-332.
13. Jaye, A., R. Sarge-Njie, M. Schim van der Loeff, J. Todd, A. Alabi, S. Sabally, T. Corrah, and H. Whittle. 2004. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. J. Infect. Dis. 189:498-505.
14. Kanki, P. J., K. U. Travers, S. MBoup, C. C. Hsieh, R. G. Marlink, A. Gueye-NDiaye, T. Siby, I. Thior, M. Hernandez-Avila, J. L. Sankale, et al. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946.
15. Leligdowicz, A., L. M. Yindom, C. Onyango, R. Sarge-Njie, A. Alabi, M. Cotten, T. Vincent, C. da Costa, P. Aaby, A. Jaye, T. Dong, A. McMichael, H. Whittle, and S. Rowland-Jones. 2007. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J. Clin. Investig. 117:3067-3074.
16. Lopes, A. R., A. Jaye, L. Dorrell, S. Sabally, A. Alabi, N. A. Jones, D. R. Flower, A. De Groot, P. Newton, R. M. Lascar, I. Williams, H. Whittle, A. Bertoletti, P. Borrow, and M. K. Maini. 2003. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HlV-1 infection. J. Immunol. 171:307-316.
17. Maecker, H. T., H. S. Dunn, M. A. Suni, E. Khatamzas, C. J. Pitcher, T. Bunde, N. Persaud, W. Trigona, T. M. Fu, E. Sinclair, B. M. Bredt, J. M. McCune, V. C. Maine, F. Kern, and L. J. Picker. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255:27-40.
18. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C. C. Hsieh, M. C. Dia, E. H. Gueye, et al. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1590.
19. McNeil, A. C., W. L. Shupert, C. A. Iyasere, C. W. Hallahan, J. A. Mican, R. T. Davey, Jr., and M. Connors. 2001. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc. Natl. Acad. Sci. USA 98:13878-13883.
20. Palmer, B. E., E. Boritz, and C. C. Wilson. 2004. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. J. Immunol. 172:3337-3347.
21. Pinto, L. A., M. J. Covas, and R. M. Victorino. 1993. T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. AIDS 7:1389-1391.
22. Pinto, L. A., M. J. Covas, and R. M. Victorino. 1995. T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals. J. Med. Virol. 47:139-144.
23. Popper, S. J., A. D. Sarr, A. Gueye-Ndiaye, S. Mboup, M. E. Essex, and P. J. Kanki. 2000. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J. Virol. 74:1554-1557.
24. Poulsen, A. G., P. Aaby, O. Larsen, H. Jensen, A. Naucler, I. M. Lisse, C. B. Christiansen, F. Dias, and M. Melbye. 1997. 9-Year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 349:911-914.
25. + T cells in human immunodeficiency virus type 2 infection. J. Virol. 80:12425-12429.
26. Sodora, D. L., and G. Silvestri. 2008. Immune activation and AIDS pathogenesis. AIDS 22:439-446.
27. Soriano, V., P. Gomes, W. Heneine, A. Holguin, M. Doruana, R. Antunes, K. Mansinho, W. M. Switzer, C. Araujo, V. Shanmugam, H. Lourenco, J. Gonzalez-Lahoz, and F. Antunes. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61:111-116.
28. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169:3400-3406.
29. Sousa, A. E., A. F. Chaves, A. Loureiro, and R. M. Victorino. 2001. Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J. Infect. Dis. 184:552-559.
30. Zheng, N. N., N. B. Kiviat, P. S. Sow, S. E. Hawes, A. Wilson, H. Diallo-Agne, C. W. Critchlow, G. S. Gottlieb, L. Musey, and M. J. McElrath. 2004. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J. Virol. 78: 13934-13942.